Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
9.86M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
920K
-
Shares change
-
+520K
-
Total reported value, excl. options
-
$1.98M
-
Value change
-
+$1.12M
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$2.15
Significant Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q1 2025
14 filings reported holding NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share as of Q1 2025.
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 920K shares
of 9.86M outstanding shares and own 9.32% of the company stock.
Largest 10 shareholders include Creative Planning (552K shares), PARSONS CAPITAL MANAGEMENT INC/RI (117K shares), BANK OF MONTREAL /CAN/ (106K shares), VANGUARD GROUP INC (28K shares), CITADEL ADVISORS LLC (26.8K shares), STIFEL FINANCIAL CORP (25.7K shares), GEODE CAPITAL MANAGEMENT, LLC (25K shares), AIGH Capital Management LLC (19.9K shares), Royal Bank of Canada (15.1K shares), and UBS Group AG (2.37K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.